News & Perspective

Mar 01, 2013

Mar 01, 2013

Study: Getting flu shot 2 years in a row may lower protection

(CIDRAP News) – Experts are puzzled by a new study in which influenza vaccination seemed to provide little or no protection against flu in the 2010-11 season—and in which the only participants who seemed to benefit from the vaccine were those who hadn't been vaccinated the season before.

Oct 25, 2011

Oct 25, 2011

Strict meta-analysis raises questions about flu vaccine efficacy

Editor’s Note: This article covers research conducted in part by CIDRAP researchers. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

See also: Public health groups say flu vaccine is best tool, despite limitations

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Sep 17, 2009

Sep 17, 2009

Study on respirators versus masks hailed as landmark

(CIDRAP News) – A study in which N95 respirators strongly outperformed surgical masks in shielding hospital workers from influenza viruses and other microbes is being hailed as a landmark in research on respiratory protection for healthcare workers.

May 16, 2007

May 16, 2007

Syndromic surveillance: faulty alarm system or useful tool?

(CIDRAP News) – At first glance, the Web page looks like an overhead shot of a fantastic game board: a map—identifiably Los Angeles—sprinkled with faceted roundels in a half-dozen colors.

Jan 20, 2006

Jan 20, 2006

Report discourages use of antivirals for seasonal flu

Jan 20, 2005 (CIDRAP News) – Researchers who analyzed numerous clinical trials concluded that the two newest antiviral drugs for influenza, oseltamivir (Tamiflu) and zanamivir (Relenza), should not routinely be used against seasonal flu—a recommendation flatly rejected by the manufacturer of oseltamivir.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»